175 related articles for article (PubMed ID: 21365764)
1. Discovering small-molecule estrogen receptor α/coactivator binding inhibitors: high-throughput screening, ligand development, and models for enhanced potency.
Sun A; Moore TW; Gunther JR; Kim MS; Rhoden E; Du Y; Fu H; Snyder JP; Katzenellenbogen JA
ChemMedChem; 2011 Apr; 6(4):654-66. PubMed ID: 21365764
[TBL] [Abstract][Full Text] [Related]
2. Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities.
Jeyakumar M; Carlson KE; Gunther JR; Katzenellenbogen JA
J Biol Chem; 2011 Apr; 286(15):12971-82. PubMed ID: 21321128
[TBL] [Abstract][Full Text] [Related]
3. A set of time-resolved fluorescence resonance energy transfer assays for the discovery of inhibitors of estrogen receptor-coactivator binding.
Gunther JR; Du Y; Rhoden E; Lewis I; Revennaugh B; Moore TW; Kim SH; Dingledine R; Fu H; Katzenellenbogen JA
J Biomol Screen; 2009 Feb; 14(2):181-93. PubMed ID: 19196699
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and in vitro biological evaluation of small molecule inhibitors of estrogen receptor alpha coactivator binding.
Rodriguez AL; Tamrazi A; Collins ML; Katzenellenbogen JA
J Med Chem; 2004 Jan; 47(3):600-11. PubMed ID: 14736241
[TBL] [Abstract][Full Text] [Related]
5. Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interaction.
Gunther JR; Moore TW; Collins ML; Katzenellenbogen JA
ACS Chem Biol; 2008 May; 3(5):282-6. PubMed ID: 18484708
[TBL] [Abstract][Full Text] [Related]
6. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
Dutertre M; Smith CL
Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
[TBL] [Abstract][Full Text] [Related]
7. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
8. Development of heterodimeric estrogen receptor alpha antagonists to target simultaneously the ligand and coactivator binding site.
Hörmann N; Kalchschmid C; Grabher P; Grassmayr I; Kapitza P; Kaserer T; Gust R
Arch Pharm (Weinheim); 2023 Jul; 356(7):e2200638. PubMed ID: 37173820
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel estrogen receptor alpha antagonists.
Shao D; Berrodin TJ; Manas E; Hauze D; Powers R; Bapat A; Gonder D; Winneker RC; Frail DE
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):351-60. PubMed ID: 15145444
[TBL] [Abstract][Full Text] [Related]
11. Two panels of steroid receptor luciferase reporter cell lines for compound profiling.
Sedlák D; Paguio A; Bartůněk P
Comb Chem High Throughput Screen; 2011 May; 14(4):248-66. PubMed ID: 21375502
[TBL] [Abstract][Full Text] [Related]
12. A new small molecule inhibitor of estrogen receptor alpha binding to estrogen response elements blocks estrogen-dependent growth of cancer cells.
Mao C; Patterson NM; Cherian MT; Aninye IO; Zhang C; Montoya JB; Cheng J; Putt KS; Hergenrother PJ; Wilson EM; Nardulli AM; Nordeen SK; Shapiro DJ
J Biol Chem; 2008 May; 283(19):12819-30. PubMed ID: 18337247
[TBL] [Abstract][Full Text] [Related]
13. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
[TBL] [Abstract][Full Text] [Related]
14. In silico identification of novel inhibitors targeting the DNA-binding domain of the human estrogen receptor alpha.
Cao H; Sun Y; Wang L; Pan Y; Li Z; Liang Y
J Steroid Biochem Mol Biol; 2021 Oct; 213():105966. PubMed ID: 34416373
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel natural compound inhibitors targeting estrogen receptor α by an integrated virtual screening strategy.
Yu E; Xu Y; Shi Y; Yu Q; Liu J; Xu L
J Mol Model; 2019 Aug; 25(9):278. PubMed ID: 31463793
[TBL] [Abstract][Full Text] [Related]
16. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
17. In search of novel drug target sites on estrogen receptors using RNA aptamers.
Xu D; Chatakonda VK; Kourtidis A; Conklin DS; Shi H
Nucleic Acid Ther; 2014 Jun; 24(3):226-38. PubMed ID: 24588102
[TBL] [Abstract][Full Text] [Related]
18. Role of estrogen receptor ligand and estrogen response element sequence on interaction with chicken ovalbumin upstream promoter transcription factor (COUP-TF).
Klinge CM
J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):1-19. PubMed ID: 10619353
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptor.
LaFrate AL; Gunther JR; Carlson KE; Katzenellenbogen JA
Bioorg Med Chem; 2008 Dec; 16(23):10075-84. PubMed ID: 18976929
[TBL] [Abstract][Full Text] [Related]
20. Integrated Model of Chemical Perturbations of a Biological Pathway Using 18 In Vitro High-Throughput Screening Assays for the Estrogen Receptor.
Judson RS; Magpantay FM; Chickarmane V; Haskell C; Tania N; Taylor J; Xia M; Huang R; Rotroff DM; Filer DL; Houck KA; Martin MT; Sipes N; Richard AM; Mansouri K; Setzer RW; Knudsen TB; Crofton KM; Thomas RS
Toxicol Sci; 2015 Nov; 148(1):137-54. PubMed ID: 26272952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
